glp-1 medications dizziness side effect Managing Effects of Receptor Agonists – Transformation Weight Control glp 1 side effects dizziness

If your symptoms are severe, persistent, or accompanied by other symptoms like belly pain, contact your healthcare provider

The increasing awareness about the benefits of these medications among healthcare providers and patients, alongside evolving lifestyle patterns leading to obesity, underscores the potential of this market segment for sustained growth

This ensures proper monitoring, support and safety

At approximately $350 per month ($4,200 per year), which reflects typical injectable maintenance dosing, an individual starting at 240 pounds would lose about 36 pounds over 12 months, translating to roughly $116.67 per pound lost

Allen RW, Schwartzman E, Baker WL, Coleman CI, Phung OJ

It's worth noting that tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist, representing a distinct but related medication class with similar clinical effects